-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
(A) shows 9 independent migration trajectories from 3 mixed control sgRNAs 1-3 clones and 3 mixed IGFBP2 sgRNAs 3 and 6 clones
"Oncotarget" published "Diverse transcriptional regulation and functional effects revealed by CRISPR/Cas9-directed epigenetic editing", reporting that the full function of this process is essential for the determination of tissue homeostasis and cell fate
It is worth noting that this modification resulted in the opposite expression profile of target genes in different cancer cell models, and affected the expression of mesenchymal genes CDH1, VIM1, TGFB1 and apoptosis marker BCL2
Dr.
Examples of various genes having opposite effects, for example, DNA methylation may be one of the driving factors of these opposite effects
In this study, the authors focused on insulin-like growth factor binding protein 2, which is a recently discovered multitasking gene that is regulated by DNA methylation and has also been reported as a tumor-promoting and suppressor gene
DNA methylation involves an important mechanism involving transcriptome regulation based on the CpG dinucleotide occupying the 5'-methylcytosine chemical group
The Vizoso/van Rheenen research team concluded in their Oncotarget research output, “Our research emphasizes the exploration of epigenetic editing in different tumor environments by revealing the important consequences of epigenetic editing on transcriptome regulation and tumor cell behavior.
Original search:
10.
Article title
Diverse transcriptional regulation and functional effects revealed by CRISPR/Cas9-directed epigenetic editing
